Asthma is a serious global health problem impacting all age groups and with increasing prevalence.
The focus of our research is how to improve the quality of life for patients while also simplifying and increasing efficiency for healthcare providers.
Asthma is a common respiratory disease affecting up to 18% of the population. It is characterized by chronic airway inflammation that creates airflow limitations with symptoms such as wheeze, shortness of breath, chest tightness and cough.
There are many factors that trigger Asthma for example exercise, allergens, change in weather, or viral respiratory infections – making asthma vary over time and in intensity.
The long-term goals of asthma management are to achieve good symptom control, and to minimize future risk of exacerbation and fixed airflow limitation.
To achieve this patients need to be provided with education and simple tools for self management,. This includes the use of a asthma action plan, with self-monitoring of symptoms and peak flow with actions how to adjust treatment is the cornerstone of effective treatment.
The goals of asthma management in young children are: To achieve good control of symptoms and maintain normal activity levels and to minimize the risk of asthma flare-ups, impaired lung development and medication side-effects.Maintaining normal activity levels is particularly important in young children because engaging in play is important for their normal social and physical development.
A recent Dutch study (2017) concluded that routine outpatient visits could be replaced by monitoring asthmatic children via eHealth instead of traditional care. The results showed that symptom-free days were reduced and asthma control improved in the group using the online care at a lower cost.
AsthmaTuner has since August 2016 been evaluated in a randomized controlled multicenter trial with a children group from Astrid Lindgren’s Children’s Hospital, Karolinska University Hospital and an adult group from the primary health care sector in Stockholm, Sweden. The study evaluates the effect of AsthmaTuner on patients’ asthma status, quality of life and adherence to treatment compared to conventional treatment.
Preliminary results from the study are looking promising. The full study will be presented during fall 2018.
“Imagine if we never need to go to the emergency again”
“I felt I could spend more days in school thanks to AsthmaTuner”
AsthmaTuner is a CE marked self-management system for asthma. The CE marking means that the system meets the essential requirements of all relevant European Medical Device Directives. The Directives outline the safety and performance requirements for medical devices in the European Union. Our CE mark covers all elements of the AsthmaTuner solution, including the app, the digital spirometer and the healthcare interface.
The AsthmaTuner system is one of few app-based solutions that have received approval from the Swedish Medical Product Agency. The approval was received in 2016.